Daniel Thomas

With FDA rules ending the era of compounded weight loss drugs, Arizona providers are pivoting to guide patients toward safer, manufacturer-direct options.

As Atlassian's Data Center EOL looms, Perforce launches a secure Gliffy app to help regulated industries migrate to the cloud without data leaving their environment.

Aethlon Medical's Hemopurifier device targets inflammatory particles in Long COVID, opening a vast new market beyond its core oncology focus.

Gilat Satellite Networks' new defense contract for a transportable ground terminal signals a strategic shift into the booming geospatial intelligence market.

A new joint venture in Arkansas plans to revive domestic magnesium production using clean tech, aiming to secure a critical mineral supply for US defense.

Guggenheim's latest fund distributions include a 'return of capital.' We break down what this means for your tax bill and what it signals about the market.

The retail REIT is paying a higher interest rate to extend its debt maturity to 2035, a strategic move signaling confidence in a shifting market.

Alaris Equity Partners shatters deployment records with a $92M debenture offering and a key US$30M investment into the resilient healthcare sector.

The REIT's new convertible debenture provides capital for acquisitions but at a higher cost, highlighting a strategic balancing act in a recovering market.

State Street consolidates its massive SPDR ETF suite, ending a key partnership to enhance investor tools and tighten its grip in the asset management race.

Struggling with financial headwinds, Rail Vision is making a bold leap, acquiring a quantum computing firm to revolutionize railway safety. Is it genius or desperation?

Post's new $1.3B bond deal extends its debt maturity but at a higher cost. We analyze the market's mixed reaction and what it means for future growth.

A tiny 0.12% stake disclosure seems trivial, but it offers a masterclass in reading M&A signals—a vital skill for investors in any sector.

A $12M HKD donation to fire victims highlights crypto's pivot to social impact, a strategic move to build trust in a scrutinized global market.

mesm Tokyo's 'NIPPON Dance Night' blends Bon Odori dancing and Moët & Chandon, setting a new standard for immersive cultural celebrations.

Singapore's Cuprina Holdings has 180 days to fix its sub-$1 stock price. A deep dive into the financial woes and strategic plays behind the delisting threat.

RadCred's new AI platform promises fair holiday loans for those with poor credit, but can it offer a true lifeline without trapping borrowers in high-cost debt?

Dynamic Funds' estimated distributions reveal a massive payout for its gold ETF, reflecting a banner year for mining stocks. Here's what it means for investors.

China's Gan & Lee launches a Phase 3 trial for a once-monthly obesity drug, challenging the weekly dominance of Wegovy and Zepbound with a focus on adherence.

The FDA’s decision on NMN is a game-changer. It clears the path for legal sales but ignites a battle over product purity and scientific proof.